Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Catching breath

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Dec 27, 2021 1:32am

297 Views

Post# 34263229

RE:RE:RE:Catching breath

Luckily with the treasury they have there is no need for that this year and if they can get the SP up there will be more coming in with warrants. Would be nice to have more reach with our IR but presenting to 600 transplant professionals should get the word out. It's good timing with the last article on Viacyte. Everything could come together and with any luck we might see a sustained step up from last year without the Doug Loe PT / financing ceiling.

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism